Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Cellebrite DI's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $84.9 million for Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 43.75% year-over-year to $84.9 million in Q4 2025; TTM through Dec 2025 was $84.9 million, a 43.75% increase from a year earlier, with the FY2025 full-year figure at $84.9 million, up 43.75% from the prior year.
• Total Non-Current Liabilities rose to $84.9 million in Q4 2025 per CLBT's latest filing, from $69.7 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $359.5 million in Q2 2024 and bottomed at $41.4 million in Q3 2021.
• The 5-year median for Total Non-Current Liabilities is $124.8 million (2022), against an average of $149.8 million.
• Across the five-year window, Total Non-Current Liabilities soared 466.45% in 2021 and plunged 81.76% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $226.6 million in 2021, then slumped by 46.3% to $121.7 million in 2022, then jumped by 101.27% to $244.8 million in 2023, then slumped by 75.89% to $59.0 million in 2024, then soared by 43.75% to $84.9 million in 2025.
• Per Business Quant, the three latest CLBT Total Non-Current Liabilities figures stand at $84.9 million (Q4 2025), $69.7 million (Q3 2025), and $69.0 million (Q2 2025).